- Home
- LNSR vs ENTX Comparison
LNSR vs ENTX Comparison
Compare LNSR & ENTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNSR
- ENTX
- Stock Information
- Founded
- LNSR 2004
- ENTX 2010
- Country
- LNSR United States
- ENTX Israel
- Employees
- LNSR N/A
- ENTX N/A
- Industry
- LNSR Medical Electronics
- ENTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LNSR Health Care
- ENTX Health Care
- Exchange
- LNSR Nasdaq
- ENTX Nasdaq
- Market Cap
- LNSR 63.4M
- ENTX 67.2M
- IPO Year
- LNSR N/A
- ENTX 2018
- Fundamental
- Price
- LNSR $7.83
- ENTX $2.25
- Analyst Decision
- LNSR
- ENTX Strong Buy
- Analyst Count
- LNSR 0
- ENTX 1
- Target Price
- LNSR N/A
- ENTX $10.00
- AVG Volume (30 Days)
- LNSR 47.6K
- ENTX 54.3K
- Earning Date
- LNSR 11-07-2024
- ENTX 11-08-2024
- Dividend Yield
- LNSR N/A
- ENTX N/A
- EPS Growth
- LNSR N/A
- ENTX N/A
- EPS
- LNSR N/A
- ENTX N/A
- Revenue
- LNSR $48,868,000.00
- ENTX $99,000.00
- Revenue This Year
- LNSR $25.07
- ENTX N/A
- Revenue Next Year
- LNSR $24.95
- ENTX N/A
- P/E Ratio
- LNSR N/A
- ENTX N/A
- Revenue Growth
- LNSR 21.29
- ENTX 607.14
- 52 Week Low
- LNSR $2.33
- ENTX $0.52
- 52 Week High
- LNSR $8.17
- ENTX $3.35
- Technical
- Relative Strength Index (RSI)
- LNSR 57.90
- ENTX 68.35
- Support Level
- LNSR $7.13
- ENTX $2.02
- Resistance Level
- LNSR $7.98
- ENTX $2.28
- Average True Range (ATR)
- LNSR 0.47
- ENTX 0.17
- MACD
- LNSR -0.06
- ENTX 0.04
- Stochastic Oscillator
- LNSR 63.33
- ENTX 77.01
About LNSR LENSAR Inc.
LENSAR Inc is a commercial-stage medical device company focused on designing, developing and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency and reproducibility by providing imaging, simplified procedure planning, efficient design and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. The consumable portion of the system consists of a disposable patient interface device, or PID, kit and a procedure license. Each procedure on each system requires the use of a PID kit.
About ENTX Entera Bio Ltd.
Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to significantly shift a treatment paradigm. Its product candidates are; EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism are first-in-class mini tablet formulations of synthetic human PTH (1-34) (teriparatide), designed to have differing pharmacokinetic, or PK, profiles.